MetLife Investment Management’s Climb Bio, Inc. Common Stock CLYM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-17,769
Closed -$90.4K 2870
2024
Q3
$90.4K Buy
+17,769
New +$90.4K ﹤0.01% 2663